New Crohn's drug shows promise in major trial

NCT ID NCT07577843

First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study tests a new medicine, JNJ-78934804, against an existing drug (guselkumab) in 460 people with moderate-to-severe Crohn's disease. The goal is to see if the new drug can reduce symptoms and heal the gut lining better at 48 weeks. Participants must have had Crohn's for at least 12 weeks and have active disease. This is a long-term treatment, not a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bezmialem University Medical Faculty

    RECRUITING

    Istanbul, 34093, Turkey (Türkiye)

  • Bnai Zion Medical Center

    RECRUITING

    Haifa, 31048, Israel

  • Clinnova Research

    RECRUITING

    Anaheim, California, 92805, United States

  • GCP Clinical Research

    RECRUITING

    Tampa, Florida, 33609, United States

  • GI Research Institute (G.I.R.I.)

    RECRUITING

    Vancouver, British Columbia, V6Z 2K5, Canada

  • Gastro SB Clinic

    RECRUITING

    Chula Vista, California, 91910, United States

  • Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital

    RECRUITING

    Sapporo, 060-0033, Japan

  • IBD SA

    RECRUITING

    Kurralta Park, 5037, Australia

  • Japanese Red Cross Kumamoto Hospital

    RECRUITING

    Kumamoto, 861-8520, Japan

  • Japanese Red Cross Osaka Hospital

    RECRUITING

    Osaka, 543-8555, Japan

  • Kagoshima IBD Gastroenterology Clinic

    RECRUITING

    Kagoshima, 892-0843, Japan

  • Kocaeli University Medical Faculty

    RECRUITING

    Kocaeli, 41001, Turkey (Türkiye)

  • London Digestive Disease Institute

    RECRUITING

    London, Ontario, N6K 1M6, Canada

  • Meir Medical Center

    RECRUITING

    Kfar Saba, 44281, Israel

  • Mersin University Medical Faculty

    RECRUITING

    Mersin, 33343, Turkey (Türkiye)

  • National Hospital Organization Hirosaki National Hospital

    RECRUITING

    Hirosaki, 036-8545, Japan

  • New York Gastroenterology Associates

    RECRUITING

    New York, New York, 10075, United States

  • Peak Gastroenterology Associates

    RECRUITING

    Colorado Springs, Colorado, 80907, United States

  • Rambam Medical Center

    RECRUITING

    Haifa, 3109601, Israel

  • Sanchez Clinical Research, Inc

    RECRUITING

    Miami, Florida, 33157-6575, United States

  • Sheba Medical Center

    RECRUITING

    Ramat Gan, 52621, Israel

  • Tel Aviv Sourasky Medical Center

    RECRUITING

    Tel Aviv, 64239, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.